<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00521170</url>
  </required_header>
  <id_info>
    <org_study_id>A00373</org_study_id>
    <secondary_id>Eudract Number: 2004-001089-41</secondary_id>
    <nct_id>NCT00521170</nct_id>
  </id_info>
  <brief_title>Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.</brief_title>
  <official_title>Randomized, Monocenter, Double Blind, Placebo-controlled, Single Oral Dose, Three-way Cross Over Study, to Compare Levocetirizine and Desloratadine on Allergen-induced Wheal and Flare Reaction During 24 Hours in 18 Adult Allergic Volunteers.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UCB Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UCB Pharma</source>
  <brief_summary>
    <textblock>
      Compare the activity of 5 mg levocetirizine and 5 mg desloratadine on allergen-induced wheal
      and flare reaction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">January 2005</completion_date>
  <primary_completion_date type="Actual">January 2005</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare the activity of levocetirizine and desloratadine on allergen-induced wheal and flare reaction. Response to allergen administered by skin prick test (SPT) measured by the wheal and flare surface areas</measure>
    <time_frame>15 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the AUC from pre-dose to 24 hours post-dose between levocetirizine and placebo and between desloratadine and placebo obtained for wheal and for flare areas. Compare the AUC from pre-dose to 12 hours post-dose</measure>
  </secondary_outcome>
  <condition>Allergy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levocetirizine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female allergic volunteers: Diagnosed allergy based on medical history and on
             positivity to skin tests to at least one of the standardized allergen including grass
             pollens, tree pollens, house dust mites, cat and dog dander and with a positive RAST
             for the specific selected allergen ≥ class 2

        Exclusion Criteria:

          -  Pregnancy or lactating females, or females with childbearing potential without
             reliable contraception

          -  History or presence of any chronic or acute illness or disorder capable of altering
             the absorption, metabolism or elimination of drugs, or constituting a risk factor when
             taking the trial medication

          -  Heavy caffeine drinker (&gt; 5 cups of coffee, tea, cola, etc … per day)

          -  Any drug treatment, including prescribed or non-prescription medicines (except
             hormonal contraceptives or post-menopausal hormonal replacement therapy for females
             and occasional use of paracetamol not exceeding 2 g/day with a maximum dose of 10 g
             per 14 days), taken from 14 days before study drug administration; the wash-out period
             after intake of systemic corticosteroids is at least 4 weeks

          -  Known allergy/intolerance to the study drug or any medicine chemically related to
             study drug or its excipients (lactose, cellulose...)

          -  Participation in another clinical trial, blood donation or significant blood loss (&gt;
             450 mL) less than 12 weeks before the study drug administration

          -  Skin irritant or 48 hours UV exposure before each visit

          -  Immunotherapy received during the current year

          -  Any clinical conditions that, in the opinion of the Investigator, would make the
             subject unsuitable for the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>UCB Clinical Trial Call Center</last_name>
    <role>Study Director</role>
    <affiliation>UCB Pharma</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Illkirch</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.ucb.com/_up/ucb_com_patients/documents/A00373_CSS_20070807.pdf</url>
    <description>Clinical Study Summary on UCB.com</description>
  </link>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 24, 2007</study_first_submitted>
  <study_first_submitted_qc>August 24, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2007</study_first_posted>
  <last_update_submitted>December 13, 2013</last_update_submitted>
  <last_update_submitted_qc>December 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2013</last_update_posted>
  <keyword>Levocetirizine</keyword>
  <keyword>Wheal and flare</keyword>
  <keyword>Allergic</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levocetirizine</mesh_term>
    <mesh_term>Cetirizine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

